Eurofins Amatsigroup ǀ Your cDmo partner

Frédéric Gaussens from Eurofins Amatsigroup (CDMO) giving an overview of the services they provide…

Eurofins Amatsigroup is a leading international CDMO focusing on drug product development for chemical/biological entities and drug substance development for biologics. See Frédéric Gaussens, VP BD & Strategy, ITW at 2018 CPhI and learn more about our key expertises (highly potent compounds, poorly soluble drugs, lyophilisation processes, immunotherapies, orphan drugs, pediatric dosage forms…). 

Video taken at CPhI worldwide, October 2018. 

If you would like to be contacted by Eurofins Amatsigroup, please complete the form below:


    Leave a Reply

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.